As an adjuvant and complementary drug, Curcumin showed anticancer activity through inhibition of Wnt/β-catenin, Notch and PI3K/Akt/mTOR signaling pathways associated with colorectal cancer development [80]. Here, AKT1 is linked to colorectal cancer.